首页    期刊浏览 2025年02月17日 星期一
登录注册

文章基本信息

  • 标题:Asp125 and Thr130 in Transmembrane Domain 3 Are Major Sites of α1b-Adrenergic Receptor Antagonist Binding
  • 本地全文:下载
  • 作者:Kazuya Takahashi ; Murad Hossain ; Maruf Ahmed
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2007
  • 卷号:30
  • 期号:10
  • 页码:1891-1894
  • DOI:10.1248/bpb.30.1891
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Site-directed mutagenesis was used to investigate the molecular interactions involved in prazosin binding to the human α1b-adrenergic receptor (α1b-AR) receptor. Based on molecular modeling studies, Thr130 and Asp125 in transmembrane region III of the α1b-AR receptor were found to interact with prazosin. Thr130 and Asp125 were mutated to alanine (Ala) and expressed in HEK293 cells. The radioligand [3H]prazosin did not show any binding to Asp125Ala mutant of α1b-AR. Therefore, it was not possible to find any prazosin affinity to the mutant using the radioligand [3H]prazosin. The mutation also abolished phenylephrine-stimulated inositol phosphate (IP) formation of [3H] myo -inositol. On the other hand, the Thr130Ala mutant showed reduced binding affinity for [3H]prazosin (dissociation constant, K d 674.27 p M versus 90.27 p M for the wild-type receptor) and had reduced affinity for both tamsulosin and prazosin (11-fold and 9-fold, respectively). However, the Thr130Ala mutant receptor retained the ability to stimulate the formation of [3H] myo -inositol. The results provide direct evidence that Asp125 and Thr130 are responsible for the interactions between α1b-AR receptor and radioligand [3H]prazosin as well as tamsulosin.
  • 关键词:prazosin;α1b-adrenergic receptor receptor;mutagenesis;binding site
国家哲学社会科学文献中心版权所有